Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients
Clinical trial NCT03032614 · WITHDRAWN
Trial details
- NCT number
- NCT03032614
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-30
- Primary completion
- 2019-03-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.